| mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |